Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Pharmaceuticals (MIST) Cash from Investing Activities: 2018-2024

Historic Cash from Investing Activities for Milestone Pharmaceuticals (MIST) over the last 7 years, with Dec 2024 value amounting to $8.3 million.

  • Milestone Pharmaceuticals' Cash from Investing Activities fell 213.43% to -$17.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$57.1 million, marking a year-over-year decrease of 181.61%. This contributed to the annual value of $8.3 million for FY2024, which is 74.16% up from last year.
  • Latest data reveals that Milestone Pharmaceuticals reported Cash from Investing Activities of $8.3 million as of FY2024, which was up 74.16% from $4.8 million recorded in FY2023.
  • Milestone Pharmaceuticals' Cash from Investing Activities' 5-year high stood at $70.0 million during FY2021, with a 5-year trough of -$70.0 million in FY2020.
  • Moreover, its 3-year median value for Cash from Investing Activities was $4.8 million (2023), whereas its average is -$14.7 million.
  • In the last 5 years, Milestone Pharmaceuticals' Cash from Investing Activities crashed by 18,129.17% in 2020 and then spiked by 200.00% in 2021.
  • Yearly analysis of 5 years shows Milestone Pharmaceuticals' Cash from Investing Activities stood at -$70.0 million in 2020, then soared by 200.00% to $70.0 million in 2021, then tumbled by 181.61% to -$57.1 million in 2022, then spiked by 108.33% to $4.8 million in 2023, then surged by 74.16% to $8.3 million in 2024.